Evidence map›Paper›PMID 22896671›Full record

ArticleMolecular pharmacology2012

The orphan nuclear receptor DAX-1 functions as a potent corepressor of the constitutive androstane receptor (NR1I3).

Elizabeth M Laurenzana, Tao Chen, Malavika Kannuswamy, Brian E Sell, Stephen C Strom, Yong Li, Curtis J Omiecinski

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 15 citations in OpenAlex.

  1. Regulation of PXR and CAR by protein-protein interaction and signaling crosstalk.Expert opinion on drug metabolism & toxicology · 2016
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Elizabeth M LaurenzanaCenter for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Tao Chen
Malavika Kannuswamy
Brian E Sell
Stephen C Strom
Yong Li
Curtis J Omiecinski
Pennsylvania State University · US

Funding

Targeting Dynamics of CAR and PXR in the Mouse and Human GenomesR01GM066411 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI OMIECINSKI, CURTIS J · 2002 to 2017
$4.5M
NIGMS NIH HHS GM066411NIGMS NIH HHS R01 GM066411
6 · The paper itself

Abstract

Regulation of gene transcription is controlled in part by nuclear receptors that function coordinately with coregulator proteins. The human constitutive androstane receptor (CAR; NR1I3) is expressed primarily in liver and regulates the expression of genes involved in xenobiotic metabolism as well as hormone, energy, and lipid homeostasis. In this report, DAX-1, a nuclear receptor family member with corepressor properties, was identified as a potent CAR regulator. Results of transaction and mutational studies demonstrated that both DAX-1's downstream LXXLL and its PCFQVLP motifs were critical contributors to DAX-1's corepression activities, although two other LXXM/LL motifs located nearer the N terminus had no impact on the CAR functional interaction. Deletion of DAX-1's C-terminal transcription silencing domain restored CAR1 transactivation activity in reporter assays to approximately 90% of control, demonstrating its critical function in mediating the CAR repression activities. Furthermore, results obtained from mammalian two-hybrid experiments assessing various domain configurations of the respective receptors showed that full-length DAX-1 inhibited the CAR-SRC1 interaction by approximately 50%, whereas the same interaction was restored to 90% of control when the DAX-1 transcription silencing domain was deleted. Direct interaction between CAR and DAX-1 was demonstrated with both alpha-screen and coimmunoprecipitation experiments, and this interaction was enhanced in the presence of the CAR activator 6-(4-chlorophenyl)imidazo[2,1-b]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime (CITCO). Results obtained in primary human hepatocytes further demonstrated DAX-1 inhibition of CAR-mediated CITCO induction of the CYP2B6 target gene. The results of this investigation identify DAX-1 as a novel and potent CAR corepressor and suggest that DAX-1 functions as a coordinate hepatic regulator of CAR's biological function.

Indexed as

Amino Acid SequenceAryl Hydrocarbon HydroxylasesConstitutive Androstane ReceptorCo-Repressor ProteinsCytochrome P-450 CYP2B6DAX-1 Orphan Nuclear ReceptorGenes, ReporterHepatocytesHumansImmunoprecipitationLuciferasesMolecular Sequence DataMutationOxidoreductases, N-DemethylatingOximesPrimary Cell Culture6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oximeAryl Hydrocarbon HydroxylasesConstitutive Androstane ReceptorCo-Repressor ProteinsCYP2B6 protein, humanCytochrome P-450 CYP2B6DAX-1 Orphan Nuclear ReceptorLuciferasesNR1I3 protein, humanOxidoreductases, N-DemethylatingOximesProtein IsoformsReceptors, Cytoplasmic and NuclearThiazoles

Identifiers

PMID22896671
PMCPMC3477224
OpenAlexW2127071218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.